High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial

AIMS: We sought to assess the risk of major adverse cardiovascular events (MACE) by utilizing high‐sensitivity C‐reactive protein (hsCRP) level and low‐density lipoprotein cholesterol (LDL‐C) in patients with type 2 diabetes and recent acute coronary syndrome. MATERIALS AND METHODS: Study participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, You‐Cheol, Morrow, David A., Cannon, Christopher P., Liu, Yuyin, Bergenstal, Richard, Heller, Simon, Mehta, Cyrus, Cushman, William, Bakris, George L., Zannad, Faiez, White, William B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836896/
https://www.ncbi.nlm.nih.gov/pubmed/29064626
http://dx.doi.org/10.1111/dom.13136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836896/
https://www.ncbi.nlm.nih.gov/pubmed/29064626
http://dx.doi.org/10.1111/dom.13136

Ejemplares similares